Group health plans and carriers will soon be required to report certain demographic and spending information about a plan’s prescription drug expenditures, a requirement that is a part of the Consolidated Appropriations Act of 2021 (CAA) passed in 2020. Initially deferred from its original due date, reporting for 2020 and 2021 calendar years is due this year on December 27, 2022. For all subsequent years, reporting is due annually by June 1st.
The CAA amended the Public Health Service Act (PHSA) to require group health plans and carriers to submit general and spending information about the plan, primarily related to prescription drug expenditures (“Pharmacy Reporting”). In turn, the Departments must use this data to publish public reports on prescription drug reimbursements, pricing trends, and the impact of prescription drug costs on premium costs.
The enforcement for the 2020 and 2021 reporting was delayed and now the first reporting will be due December 27, 2022, as explained in FAQs issued August 20, 2021. For calendar year 2022 and all subsequent years, the reporting is due by June 1st.
Pharmacy Reporting Requirement
As explained further in the interim final rule, the pharmacy reporting requirement generally applies to group health plans (both fully insured and self-insured) and carriers. Examples of information that must be reported include:
- Premium amounts, including the average monthly premium paid by both employees and the employer;
- Annual health care services spend categorized by types of cost (including hospital costs, health care provider and clinical service costs, costs for prescription drugs, and other medical costs);
- Information on the 50 most frequently dispensed brand prescription drugs, and the total number of paid claims for each drug;
- The 50 most costly prescription drugs by total annual spending, and the annual amount spent by the plan or coverage for each drug; and
- The 50 prescription drugs with the greatest increase in plan expenditures and for each such drug, the change in amounts expended by the plan or coverage in each plan year.
The reported information can be submitted on an aggregate basis, with the only “plan-level” information being general plan information. Importantly, plans can satisfy their reporting obligations by having third-parties, such as carriers, third-party administrators (TPAs), or pharmacy benefit managers (PBMs) submit the required information on their behalf, explained further below.
Employer Action Items
As mentioned, group health plans and carriers are required to submit their first pharmacy report by December 27, 2022 (for calendar years 2020 and 2021). To comply with this new requirement, employer plan sponsors will need the assistance of their carriers, TPAs, PBMs, or other similar vendors. In fact, the Departments stated in the interim final rule that they anticipate it will be rare for group health plans to report the information on their own, as employers generally do not have access to all of the information required. As such, employers should do the following, based on their funding type:
- Fully insured: Confirm with their carriers that they will be complying with this requirement, as it appears that most carriers are completing the reporting on behalf of fully insured plans. In addition, employers should consider entering into a written agreement requiring their carrier to complete this reporting. Employers with fully insured plans who contract with their carrier to complete the reporting will not be held liable for any failure to report.
- Self-insured: Identify and contract with a TPA/PBM to fulfill this requirement on the plan’s behalf and confirm the TPA/PBM has the necessary plan information to comply with the requirement. Self-insured employers are ultimately liable for any failure to report, regardless of whether they enter into a written agreement with their TPA/PBM to complete reporting. However, employers may still consider entering into a written agreement that requires their TPA/PBM to complete the reporting to protect itself contractually against a potential vendor failure.